Key result
Acute CPAP reduces ETCO2 and increases HRV in patients with chronic heart failure.
Why the study?
The physiological influence of acute treatment with different levels of CPAP on cardiac autonomic balance and respiratory responses in stable COPD and CHF patients was not well characterized.
Does acute CPAP treatment improve cardiac autonomic modulation and respiratory responses in patients with stable COPD and CHF?
RCT (n=28)
Double-blind
Randomized
No
Does acute CPAP treatment improve cardiac autonomic modulation and respiratory responses in patients with stable COPD and CHF?
Acute CPAP treatment improves neural control of heart rate in patients with stable CHF, though the optimal pressure level varies by underlying disease.
Answers are grounded in this paper and cite their sources.
Acute CPAP may enhance autonomic modulation in stable CHF; extends evidence to comorbid COPD populations.
INTRODUCTION: Non-invasive ventilation may improve autonomic modulation and ventilatory parameters in severely disabled patients. The aim of the present study was to evaluate the physiological influence of acute treatment with different levels of continuous positive airway pressure (CPAP) on the autonomic balance of heart and respiratory responses in patients with stable chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF). MATERIALS AND METHODS: A COPD group (n = 10), CHF group (n = 8) and healthy subjects (n = 10) were evaluated. The participants were randomized to receive three different levels of CPAP on the same day: sham ventilation (Sham), 5 cmH(2)0 (CPAP5) and 10 cmH(2)0 (CPAP10) for 10 min. Respiratory rate, end tidal carbon dioxide (E(T)CO(2)), peripheral oxygen saturation (SpO(2)), heart rate (HR), blood pressure and heart rate variability in the time and frequency domains were measured during spontaneous breathing and under the sham, CPAP5 and CPAP10 conditions. RESULTS: All groups experienced a reduction in E(T)CO(2) values during treatment with CPAP (p < 0.05). CPAP increased SpO(2) and HR in the COPD group (p < 0.05). The COPD group also had lower RMSSD values during treatment with different levels of CPAP when compared to the control group (p < 0.05). In the CHF group, CPAP5 and CPAP10 increased the SDNN value (p < 0.05). CPAP10 reduced the SDNN value in the COPD group (p < 0.05). CONCLUSION: The findings suggest that CPAP may cause improvements in the neural control of heart rate in patients with stable COPD and CHF. For each patient, the "best CPAP level" should be defined as the best respiratory response and autonomic balance.
No takes yet. Share an insight, caveat, or question.
Reis et al. (2010) conducted an RCT in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Heart Failure (CHF) (n=28). Continuous positive airway pressure (CPAP) vs. Sham ventilation and spontaneous breathing was evaluated on Cardiac autonomic modulation (HRV) and respiratory responses (ETCO2) (p=<0.05). Acute treatment with continuous positive airway pressure reduced end-tidal carbon dioxide across all groups and increased the SDNN index of heart rate variability in patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: